Maxine Gowen
Chairman presso PASSAGE BIO, INC.
Patrimonio netto: 15 253 $ in data 31/03/2024
Profilo
Maxine Gowen was the founder of Trevena, Inc. (founded in 2007) and held the title of Director from 2018 to 2021.
She is currently the Chairman at Passage Bio, Inc. since 2021, a Director at Conforma Therapeutics Corp., an Independent Director at Aclaris Therapeutics, Inc. since 2019, a Non-Executive Director at Merus NV since 2021, and a Director at TamuroBio, Inc. since 2021.
Dr. Gowen has also held former positions as an Independent Director at Human Genome Sciences, Inc. from 2008 to 2012, an Independent Director at Idera Pharmaceuticals, Inc., a Director at Morphotek, Inc., a Director at Santarus, Inc., a Director at Azelon Pharmaceuticals, Inc., a Director at Biotechnology Innovation Organization from 2008 to 2018, a Director at Life Sciences Pennsylvania from 2015 to 2021, an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2021, a Director at Panorama Medicine, Inc. from 2020 to 2021, an Independent Director at Aceragen, Inc. from 2016 to 2023, the President & Managing Partner at GSK Equity Investments Ltd.
from 2002 to 2005, the SVP-External Drug Discovery Excellence Center at GSK Plc from 2005 to 2007, the VP-Drug Discovery & Musculoskeletal Diseases at GSK Plc from 1992 to 2002, and the Head-Bone Cell Biology Group at the University of Bath from 1989 to 1992.
Dr. Gowen's education includes a doctorate from the University of Bath, an undergraduate degree from the University of Bristol (conferred in 1979), a doctorate from The University of Sheffield (conferred in 1984), and an MBA from The Wharton School of the University of Pennsylvania (conferred in 2002).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/06/2023 | 12 301 ( 0.02% ) | 15 253 $ | 31/03/2024 | |
MERUS N.V.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
ACERAGEN, INC.
-.--% | 10/08/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
PASSAGE BIO, INC.
-.--% | 25/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Maxine Gowen
| Società | Posizione | Inizio |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Director/Board Member | 02/07/2019 |
| PASSAGE BIO, INC. | Chairman | 31/08/2021 |
| MERUS N.V. | Director/Board Member | 28/05/2021 |
TamuroBio, Inc.
 TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Tamurobio, Inc. provides biotechnology services. The company was founded in 2019 and is headquartered in Wayne, PA. | Director/Board Member | 01/08/2019 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Precedenti posizioni note di Maxine Gowen
| Società | Posizione | Fine |
|---|---|---|
| ACERAGEN, INC. | Director/Board Member | 15/08/2023 |
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 06/06/2021 |
| TREVENA, INC. | Founder | 01/05/2021 |
Panorama Medicine, Inc.
 Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Director/Board Member | 01/01/2021 |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Maxine Gowen
| University of Bath | Doctorate Degree |
| University of Bristol | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| MERUS N.V. | Health Technology |
| TREVENA, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| Aziende private | 13 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Panorama Medicine, Inc.
Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Panorama Medicine, Inc. operates a drug discovery platform that integrates genomics, big data, and computing to find drugs that can treat diseases caused by errors during RNA processing. The company was founded by Yi Xing, Mingfu Zhu, and Douglas Black in 2018 and is headquartered in Philadelphia, PA. | Commercial Services |
| Center of Excellence For External Drug Discovery | |
TamuroBio, Inc.
TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Tamurobio, Inc. provides biotechnology services. The company was founded in 2019 and is headquartered in Wayne, PA. | Commercial Services |
| Aceragen, Inc. |
- Borsa valori
- Insiders
- Maxine Gowen
